Biomedical Research Institute, Hasselt University and School of Life Sciences, transnationale Universiteit Limburg, Diepenbeek, Belgium.
Genes Immun. 2010 Jun;11(4):326-33. doi: 10.1038/gene.2009.106. Epub 2010 Jan 14.
The receptor for the homeostatic T cell cytokine interleukin-7 (IL-7Ralpha) has recently shown genetic association to multiple sclerosis (MS). To investigate the functional contribution of IL-7Ralpha polymorphisms to the pathogenesis of MS, we correlated the IL-7Ralpha haplotypes with different T cell parameters in a group of MS patients and healthy controls. We show that carriers of one of the four IL-7Ralpha haplotypes (Hap4) show a higher expression of IL-7Ralpha (CD127) on their CD4(+) T cells, compared with noncarriers (P=0.04). Moreover, Hap4 carriers possess higher frequencies of recent thymic emigrants (RTEs, CD31(+)) in both the regulatory T cell (Treg; P=0.007) and conventional T cell (Tconv) population (P=0.0001). This effect is most pronounced within the MS population (Treg, P=0.0077; Tconv, P=0.0007), whereas in healthy controls significance was only reached for Tconv (P=0.043; Treg, P=0.11). Because previous studies showed a decreased RTE-Treg frequency in MS patients compared to healthy subjects, we here conclude that this decrease is localized within the MS population of non-Hap4 carriers. In conclusion, our findings suggest that IL-7Ralpha polymorphisms can influence T cell development and homeostasis, and thereby contribute to the altered immune regulation associated with disease development in patients with MS.
白细胞介素-7(IL-7Rα)的同源性调节剂是调节性 T 细胞(Treg)和初始 T 细胞(Tconv)发育和稳态的关键细胞因子受体。该受体最近显示与多发性硬化症(MS)存在遗传关联。为了研究 IL-7Rα多态性对 MS 发病机制的功能贡献,我们将 IL-7Rα 单倍型与一组 MS 患者和健康对照组的不同 T 细胞参数相关联。我们表明,与非携带者相比,四种 IL-7Rα 单倍型之一(Hap4)的携带者在其 CD4+T 细胞上表现出更高的 IL-7Rα(CD127)表达(P=0.04)。此外,Hap4 携带者在调节性 T 细胞(Treg;P=0.007)和常规 T 细胞(Tconv)群体中具有更高频率的近期胸腺移民(RTE,CD31+)(P=0.0001)。这种效应在 MS 人群中最为明显(Treg,P=0.0077;Tconv,P=0.0007),而在健康对照组中仅在 Tconv 中达到显著性(P=0.043;Treg,P=0.11)。由于先前的研究表明 MS 患者的 RTE-Treg 频率较健康对照者降低,因此我们在这里得出结论,这种降低局限于非 Hap4 携带者的 MS 人群中。总之,我们的研究结果表明,IL-7Rα 多态性可以影响 T 细胞的发育和稳态,并因此导致与 MS 患者疾病发展相关的免疫调节异常。